Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Agam R. Sheth is active.

Publication


Featured researches published by Agam R. Sheth.


Journal of Physical Chemistry B | 2009

Exploring the Formation of Multiple Layer Hydrates for a Complex Pharmaceutical Compound

Xin S. Zhao; J. Ilja Siepmann; Wei Xu; Y.-H. Kiang; Agam R. Sheth; S. Karaborni

The pharmaceutical compound A, 3-{2-oxo-3-[3-(5,6,7,8-tetrahydro[1,8]naphthyridin-2-yl)propyl]imidazolidin-1-yl}-3(S)-(6-methoxypyridin-3-yl)propionic acid, is known to exist in five different crystalline forms that differ in the hydration state ranging from the anhydrous desolvate over hemihydrate, dihydrate, and tetrahydrate forms to the pentahydrate. The formation of the higher hydrates and the concomitant lattice expansion leads to undesirable tablet cracking at higher humidities. In this work, particle-based simulation techniques are used to explore the hydrate formation of compound A as a function of humidity. It is found that a simulation strategy employing Monte Carlo simulations in the isobaric-isothermal and Gibbs ensembles and transferable force fields, which are not parametrized against any experimental data for compound A, is able to yield satisfactory crystal structures for the anhydrate and pentahydrate and to predict the existence of all five hydrates.


Journal of Pharmaceutical Sciences | 2010

Risk Assessment and Physicochemical Characterization of a Metastable Dihydrate API Phase for Intravenous Formulation Development

Christopher J. Mortko; Agam R. Sheth; Narayan Variankaval; Li Li; Brian T. Farrer

(1S,5R)-2-{[(4S)-azepan-4-ylamino]carbonyl}-7-oxo-2,6-diazabicyclo[3.2.0] heptane-6-sulfonic acid (Compound 1) is a β-lactamase inhibitor for intravenous administration. The objective of this preformulation study was to determine the most appropriate form of the API for development. Compound 1 can exist as an amorphous solid and four distinct crystalline phases A, B, C, and D in the solid state. Slurry experiments along with analysis of physicochemical properties were used to construct a phase diagram and select the most suitable form of the API for development. In aqueous formulations, the dihydrate form of the API was predominant and, due to the more favorable solubility and dissolution profile required for preclinical and clinical studies, a metastable form of the API was selected, and the risks associated with developing this form were evaluated.


Journal of the American Chemical Society | 2005

Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes.

Agam R. Sheth; Joseph W. Lubach; Eric J. Munson; Francis X. Muller; David J. W. Grant


Crystal Growth & Design | 2004

Polymorphism in piroxicam

Agam R. Sheth; Simon Bates; Francis X. Muller; David J. W. Grant


Crystal Growth & Design | 2005

Local Structure in Amorphous Phases of Piroxicam from Powder X-ray Diffractometry

Agam R. Sheth; Simon Bates; Francis X. Muller; David J. W. Grant


Archive | 2006

Self-emulsifying formulations of cetp inhibitors

Agam R. Sheth; Bhagwant Rege; Soumojeet Ghosh; Laman Alani; Craig McKelvey; Maria T. Cruanes


Crystal Growth & Design | 2006

Monte carlo calculations for the solid-state properties of warfarin sodium 2-propanol solvate

Collin D. Wick; J. Ilja Siepmann; Agam R. Sheth; David J.W. Grant; Sami Karaborni


Archive | 2017

SOLID DISPERSION FORMULATIONS OF ANTIVIRAL COMPOUNDS

Agam R. Sheth; Pavithra Sundararajan; Elise Miller; Justin Moser; Adam Socia; Angela M. Wagner


Archive | 2016

Fixed-Dose Combinations of Antiviral Compounds

Pavithra Sundararajan; Agam R. Sheth; Jesse Kuiper; Patrick J. Marsac; Elise Miller; Justin Moser; Adam Socia; Angela M. Wagner


Archive | 2006

Formulations d'inhibiteur de cetp

Agam R. Sheth; Bhagwant Rege; Soumojeet Ghosh; Laman Alani; Craig McKelvey; Maria T. Cruanes

Collaboration


Dive into the Agam R. Sheth's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge